450 Participants NeededMy employer runs this trial

Accessible Healthcare Model for Congenital Heart Disease

CA
Overseen ByCatherine Allen, MD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Wisconsin, Madison
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to assist individuals with congenital heart disease (CHD) in transitioning smoothly from pediatric to adult healthcare. It evaluates educational programs led by nurses and doctors to determine which is more effective in helping patients find new doctors as they age. The trial seeks CHD patients aged 12-26 who can communicate in English or Spanish and may have a disability. Participants will contribute to improving resources for others undergoing this important healthcare transition. As an unphased trial, this study provides participants the chance to contribute to valuable research that enhances healthcare transitions for future patients.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that these healthcare transition education methods are safe?

Research has shown that both Nurse-Led and Physician-Led Healthcare Transition Education are generally safe for patients with congenital heart disease (CHD) transitioning from pediatric to adult care.

For Nurse-Led Healthcare Transition Education, studies have found that these programs improve knowledge and self-management skills in adolescents and young adults with CHD. They report no significant negative effects, indicating that this approach is well-tolerated. Specifically, a clinical trial of a nurse-led education program found it safe and helpful in improving transition outcomes.

Similarly, Physician-Led Healthcare Transition Education plays a crucial role in ensuring a smooth shift to adult care. It emphasizes education and planning, which are essential for preparing patients. Existing studies show no evidence of harm or negative side effects from this method.

Overall, both types of transition education aim to support rather than treat. They focus on enhancing care coordination and patient understanding, making them low-risk options.12345

Why are researchers excited about this trial?

Researchers are excited about the Accessible Healthcare Model for Congenital Heart Disease because it introduces innovative approaches to healthcare transition education for young patients with congenital heart disease (CHD). Unlike traditional care, which often lacks a structured transition plan, this model features both nurse-led and physician-led education to better prepare patients for the transition from pediatric to adult care. By focusing on education tailored to the patient's developmental stage and involving patient support people and healthcare providers, this approach aims to improve long-term health outcomes and patient self-management, something standard treatments don't typically address.

What evidence suggests that this trial's treatments could be effective for congenital heart disease?

This trial will compare two approaches to healthcare transition education for young people with congenital heart disease (CHD): nurse-led and physician-led programs. Research has shown that nurse-led programs can significantly assist young people with CHD in transitioning from child to adult care. These programs enhance patients' understanding of their condition and improve self-management, reducing the risk of delays in accessing adult CHD care. In contrast, doctors offer personalized advice to prepare patients for the transition from pediatric to adult care. These educational sessions have been linked to better health outcomes and fewer health issues. Both nurse-led and doctor-led approaches in this trial aim to make the transition smoother and more effective for patients with CHD.13467

Who Is on the Research Team?

CA

Catherine Allen, MD

Principal Investigator

UW School of Medicine and Public Health

Are You a Good Fit for This Trial?

This trial is for people aged 12-26 with congenital heart disease who are moving from pediatric to adult care. Participants must be able to give consent or assent (with a guardian if under 18) and complete study activities in English or Spanish. Some may have disabilities.

Inclusion Criteria

I am able to agree to take part in the study when asked by my heart doctor.
I have a disability or am identified as having one in my records.
I have congenital heart disease and am between 12 and 26 years old.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

On-Study Procedures

Participants will be asked their preference for contact for relevant follow-up and may receive a copy of the QPL and aTRA prior to their clinic visit. Accessible care activities will be performed by the provider following the patient participants' enrollment in the study.

1 month
1 clinic visit

Adaptive Transition Education Procedures

Recruitment interviews and adaptive transition education activities will take place. Participating patients and their support persons may complete structured or unstructured interviews following the education session.

1 month

Follow-up

Participants are monitored for safety and effectiveness after the transition education procedures. Surveys and interviews are conducted to assess transition factors.

up to 1 year

What Are the Treatments Tested in This Trial?

Interventions

  • Nurse Lead Healthcare Transition Education
  • Physician Lead Healthcare Transition Education

Trial Overview

The study compares nurse-led versus physician-led education models to help young people with congenital heart disease transition smoothly into adult healthcare, using interviews, surveys, and visits as part of the research.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: PatientsExperimental Treatment5 Interventions
Group II: Patient Support PeopleExperimental Treatment3 Interventions
Group III: Patient Health Care ProvidersExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

Citations

Evaluating the Impact of Nurse-Led Transition Care Guidance ...

This study will contribute to the development of evidence-based transition care plans that optimize the hospital-to-home transition for children ...

Evaluation of a nurse-led multi-component transition ...

Due to improved therapeutic options, up to 97% of children born with CHD survive into adulthood [2]. However, most patients remain at risk for cardiac ...

Efficacy of An Adult Congenital Heart Disease Transition Care ...

... nurse-led intervention to prepare young people for transition to an adult care program was associated with improved knowledge of their disease. This led to ...

Transition Intervention for Adolescents With Congenital ...

A nurse-led intervention reduced the likelihood of a delay in adult CHD care and improved CHD knowledge and self-management skills.

Study Details | NCT04463446 | The Impact of an Innovative ...

With this submission, we focus on transitions in care (TiC) from pediatric to adult healthcare with a research plan designed to optimize TiC outcomes. Despite ...

Virtual transition education of rural adolescents with ...

Nurse-led virtual transition education can improve rural adolescents' and young adults' knowledge of their CHD and self-management skills. •. Pediatric ...

Multistakeholder Recommendations for Supporting ...

This study aimed to develop recommendations for a CHD transition programme driven by lived and clinical experiences.